Growth in children and adolescents with sickle cell disease in Yemen

A-W M Al-Saqladi1, H A Bin-Gadeen, B J Brabin

  • 1Faculty of Medicine & Health Sciences, Aden University, Yemen.

Insights

Growth is severely impaired in children with sickle cell disease (SCD) in Yemen, with many exhibiting low weight and height. Nutritional support and growth monitoring are crucial for comprehensive SCD care.

Area of Science:

  • Pediatrics
  • Hematology
  • Public Health

Background:

  • Physical growth is frequently impaired in children with sickle cell disease (SCD).
  • The prevalence and severity of growth impairment in SCD vary geographically.
  • Underlying factors contributing to suboptimal growth in SCD remain poorly understood.

Purpose of the Study:

  • To evaluate the growth status of children and adolescents with SCD in Yemen.
  • To utilize new World Health Organization (WHO) reference values for growth assessment.
  • To examine correlations between growth indicators, disease severity, and hematological/biochemical parameters.

Main Methods:

  • A cross-sectional study was conducted involving children under 16 years with SCD.
  • Anthropometric measurements including weight, height, mid-upper-arm circumference (MUAC), and body mass index (BMI) were collected.
  • Disease severity was quantified using a severity index (SI) score.

Main Results:

  • 45% of 102 children had low weight-for-age, 54% low height-for-age, and 35% low BMI-for-age Z-scores (<-2 SD).
  • Low height-for-age correlated with male gender (p=0.02).
  • Low weight-for-age and weight-for-height correlated with increased age (p<0.001), low weight-for-age with raised alkaline phosphatase (p=0.04), and low BMI with reduced plasma albumin (p=0.04).
  • No correlation was found between growth deficits and SI or anemia severity.

Conclusions:

  • Children and adolescents with SCD in Yemen experience significant growth impairment.
  • Integrating growth monitoring and nutritional support into the care of SCD patients is essential.
  • These interventions are vital components of comprehensive management for SCD in this population.
Abstract

Related Concept Videos

Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Changes in the Appendicular Skeleton with Age01:09

Changes in the Appendicular Skeleton with Age

The upper and lower limb initially develops as a small bulge called a limb bud, which appears on the lateral side of the early embryo. The upper limb bud appears near the end of the fourth week of development, with the lower limb bud appearing shortly after.
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...